Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C
hi
and Ly6C
lo
Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice
Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C
hi
and Ly6C
lo
Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now